Global Health questions the effectiveness of using recovered plasma in treating Corona

Geneva - Sana

Today, the World Health Organization (WHO) questioned the effectiveness of using plasma recovered from Corona to treat people with the virus, considering that the evidence for this is still "weak", after the United States issued an emergency permission to allow its use in treatment.

Reuters quoted Sumya Swaminathan, the UN chief scientist, as saying that only a small number of clinical trials on convalescent plasma have yielded results and that the evidence so far at least is not convincing enough to support its use beyond the limits of experimental treatment.

"Some trials have shown limited benefits, but they are small and their data are inconclusive so far," Swaminathan said at a press conference, stressing that: "At the present time the evidence is still of poor quality so we recommend that convalescent plasma remain an experimental treatment and should continue to be evaluated through randomized clinical trials." It is well prepared. ”

The so-called cure plasma, which has long been used to treat illnesses, has emerged as the latest focus of political tension in the race to find a cure for the disease.

Yesterday, the US Food and Drug Administration authorized the use of plasma after President Donald Trump blamed the world organization for obstructing the deployment of vaccines and drugs for "political reasons."

This technique involves taking antibody-rich plasma from patients who have recovered from Covid 19 and injecting it into the bodies of those with severe active infections in the hope of shortening the recovery time.